Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Neurobiological Tech. (NasdaqSC:NTII)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider
Location
3260 Blume Drive, Suite 500
Richmond, CA 94806
Phone: (510) 262-1730
Email: invest@ntii.com
Employees (last reported count): 6
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Historical Quote Data
 ·Free Annual Report
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Website
 ·Home Page

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 26%
·Institutional: 21% (28% of float)
(20 institutions)
·Net Inst. Selling: 488.0K shares (+15.58%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Neurobiological Technologies, Inc. is an emerging drug development company focused on the clinical evaluation and regulatory approval of neuroscience drugs. The Company develops neuroprotective and neuromodulatory agents to treat progressive neurological impairments characteristic of various nervous system disorders, including diabetic neuropathy, brain cancer, and AIDS dementia syndrome. The Company's strategy is to in-license and develop early-stage drug candidates that target major medical needs and which can be rapidly commercialized. The Company's products in development include Memantine and XERECEPT.
More from Market Guide: Expanded Business Description

Financial Summary
Neurobiological Technologies is a development stage drug development company focused on the clinical evaluation and regulatory approval of neuroscience drugs. NTI strategy is to in-license and develop early-stage drug candidates that target major medical needs. For the nine months ended 3/31/00, revenue totaled $2.5 million vs. none. Net income totaled $63 thousand vs. a loss of $2.3 million. Results reflect higher license income, and lower research and development expenses.

Recent Earnings Announcement
For the 3 months ended 06/30/2001, revenues were 2,250; after tax earnings were 1,525. (Preliminary; reported in thousands of dollars.)

More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Compensation
PayExer

Abraham Cohen, 64
Chairman of Directors
--  --  
Paul Freiman, 66
Pres and CEO
$155K$356K
Lisa Carr, M.D., Ph.D., 45
VP, Medical Affairs
103K229K
Dollar amounts are as of 30-June-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year.
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqSC:NTIIAs of 31-Aug-2001
Price and Volume
52-Week Low
on 4-Apr-2001
$1.563
Recent Price$4.49 
52-Week High
on 1-Sep-2000
$8.719
Beta0.73 
Daily Volume (3-month avg)17.2K
Daily Volume (10-day avg)37.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y]
52-Week Change-47.6%
52-Week Change
relative to S&P500
-29.7%
Share-Related Items
Market Capitalization$78.5M
Shares Outstanding17.5M
Float12.9M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq*)$0.48 
Earnings (ttm)$0.06 
Earnings (mrq)$0.08 
Sales (ttm)$0.26 
Cash (mrq*)$0.58 
Valuation Ratios
Price/Book (mrq*)9.44 
Price/Earnings (ttm)77.41 
Price/Sales (ttm)17.21 
Income Statements
Sales (ttm)$4.78M
EBITDA (ttm*)-$1.21M
Income available to common (ttm)$1.59M
Profitability
Profit Margin (ttm)33.2%
Operating Margin (ttm)-51.2%
Fiscal Year
Fiscal Year EndsJune 30
Most recent quarter
(fully updated)
31-Mar-2001
Most recent quarter
(flash earnings)
30-June-2001
Management Effectiveness
Return on Assets (ttm)16.93%
Return on Equity (ttm)21.11%
Financial Strength
Current Ratio (mrq*)10.43 
Debt/Equity (mrq*)0 
Total Cash (mrq)$3.63M
Short Interest
As of 8-Aug-2001
Shares Short230.0K
Percent of Float1.8%
Shares Short
(Prior Month)
229.0K
Short Ratio20.91 
Daily Volume11.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001, except mrq*/ttm* items as of 31-Mar-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.